Sosei submits marketing authorization application in Japan for SO-1105 for oropharyngeal candidiasis March 3, 2017
Scynexis holds initiation of clinical studies of intravenous SCY-078 following FDA communication March 3, 2017
Achaogen offers overview of R&D programs and introduces new antibiotic clinical candidate March 3, 2017
Letermovir shows promising phase III results in HCT patients for CMV infection prevention March 3, 2017
Pivotal Phase III study results for Merck & Co.'s varicella zoster virus vaccine presented March 2, 2017
RSS